Amway (Malaysia) Holdings Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amway (Malaysia) Holdings Berhad with three other
drug stores in Asia:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 915.63 million Chinese Renmimbi [US$144.53 million]
of which 97%
was Pharmaceutical Business Trade),
of South Korea
(151.26 billion Korean Won [US$141.27 million]
Hai-O Enterprise Berhad
(404.24 million Malaysian Ringgits [US$103.38 million]
of which 76%
was Multi-Level Marketing).
Amway (Malaysia) Holdings Berhad reported sales of 984.21 million Malaysian Ringgits (US$251.71 million)
December of 2017.
decrease of 9.5%
versus 2016, when the company's sales were 1.09 billion Malaysian Ringgits.